Second, SLE disease activity is positively associated with CD19+ cell APO 2.7 marker level (Table 2), but negatively associated with MAVS and caspase-9 levels (Table 3) (p < 0.05). The gene discussed is MAVS; the disease is systemic lupus erythematosus.